Trial Profile
Clinical efficacy and toxicity of single pemetrexed treatment compared with platinum-based pemetrexed doublet pemetrexed-based as first-line treatment for advanced nonsquamous nonsmall cell lung cancer (NS-NSCLC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2017
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Oxaliplatin (Primary) ; Pemetrexed (Primary) ; Dexamethasone; Folic acid; Vitamin B12 analogues
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 17 Apr 2017 New trial record
- 01 Mar 2017 Results published in the Medicine